Serum Institute of India gets $150 mn booster shot
The new collaboration is a step forward in rolling out an additional 100 million doses of safe and effective Covid-19 vaccines for low and middle-income countries.
India Global Business Staff2020-10-01T03:57:08+00:00September 30th, 2020|Guest Columns - India Global Business, Insight - India Global Business|
The new collaboration is a step forward in rolling out an additional 100 million doses of safe and effective Covid-19 vaccines for low and middle-income countries.
India Inc. Staff2020-09-25T10:53:26+00:00September 25th, 2020|iGLOBAL, iWellness|
A new smartphone app to boost the UK’s track and trace system to help control coronavirus transmissions is being rolled out across England and Wales this week, with multiple language options, including Indian languages such as Gujarati, Punjabi and Bengali.
Nadia Hatink2020-09-20T10:09:00+00:00September 20th, 2020|iGLOBAL, News & Views|
India is being nudged towards adopting a cycle-friendly strategy similar to the UK’s as a means of combating obesity, which has been linked with an increased risk of complication from Covid-19.
Aditi Khanna2020-09-22T12:32:28+00:00September 18th, 2020|iGLOBAL, News & Views|
British Indian surgeon Ajith George, working with a colleague, has created an innovative new Covid-safe face mask to protect fellow ear, nose and throat (ENT) medics from coronavirus infections in the line of duty.
India Global Business Staff2020-09-23T13:27:20+00:00September 18th, 2020|Analysis - India Global Business, India Inc Views - India Global Business|
Necessity has been the mother of invention in the response to the COVID-19 pandemic, and nowhere is this more apparent than in India. With a clear focus on affordability and low cost, here is how frugal Indian innovations have taken the commercial route to aid the fight against pandemic.
India Global Business Staff2020-09-18T10:29:52+00:00September 18th, 2020|iGLOBAL, iWellness|
The UK has begun human trials of a new antibody treatment for patients hospitalised with Covid-19. As part of the government-backed Randomised Evaluation of Covid-19 therapy (RECOVERY) Trials, monoclonal antibodies, or potent laboratory-made antibodies, will be given to about 2,000 patients in the coming weeks to see if they are effective against coronavirus. The Phase 3 open-label trial in patients hospitalised with Covid-19 will compare the effects of adding REGN-COV2 to the usual standard-of-care versus standard-of-care on its own.
India Global Business Staff2020-09-23T13:35:06+00:00September 18th, 2020|India Inc Views - India Global Business|
Unlike PCR or antibody tests, antigen tests quickly detect highly infectious individuals with a high viral load, who might be super-spreaders. That’s the reason why more Indian states are now opting for them.
Nadia Hatink2020-09-15T12:25:51+00:00September 15th, 2020|iGLOBAL, News & Views|
Indian grandmothers and their love for their grandchildren are among 100 snapshots from a Covid-19 lockdown photographic journey curated by the Duchess of Cambridge, Kate Middleton, and backed by Queen Elizabeth II.
India Inc. Staff2020-09-15T09:12:48+00:00September 15th, 2020|iGLOBAL, iWellness|
From Tuesday, Birmingham, Sandwell and Solihull – cities with a significant Global Indian representation – will fall under the government’s “areas of intervention”, with residents told not to meet with people from outside their households to control the spread of coronavirus.
Nadia Hatink2020-09-09T14:09:20+00:00September 9th, 2020|iGLOBAL, News & Views|
A Global Indian professor’s Oxford-based company revealed that its Indian partner, the Serum Institute of India (SIIPL), has begun trials of a novel virus-like particle (VLP) vaccine targeting Covid-19 which has the potential to offer a groundbreaking new approach to fighting the pandemic.